- Home
- APVO vs GCTK Comparison
APVO vs GCTK Comparison
Compare APVO & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- GCTK
- Stock Information
- Founded
- APVO 2016
- GCTK 2001
- Country
- APVO United States
- GCTK United States
- Employees
- APVO N/A
- GCTK N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- APVO Health Care
- GCTK Health Care
- Exchange
- APVO Nasdaq
- GCTK Nasdaq
- Market Cap
- APVO 4.1M
- GCTK 4.1M
- IPO Year
- APVO N/A
- GCTK N/A
- Fundamental
- Price
- APVO $3.23
- GCTK $6.42
- Analyst Decision
- APVO Strong Buy
- GCTK
- Analyst Count
- APVO 1
- GCTK 0
- Target Price
- APVO $5,920.00
- GCTK N/A
- AVG Volume (30 Days)
- APVO 6.7M
- GCTK 1.6M
- Earning Date
- APVO 08-07-2025
- GCTK 08-12-2025
- Dividend Yield
- APVO N/A
- GCTK N/A
- EPS Growth
- APVO N/A
- GCTK N/A
- EPS
- APVO N/A
- GCTK N/A
- Revenue
- APVO N/A
- GCTK N/A
- Revenue This Year
- APVO N/A
- GCTK N/A
- Revenue Next Year
- APVO N/A
- GCTK N/A
- P/E Ratio
- APVO N/A
- GCTK N/A
- Revenue Growth
- APVO N/A
- GCTK N/A
- 52 Week Low
- APVO $2.81
- GCTK $5.16
- 52 Week High
- APVO $485.37
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- APVO 34.28
- GCTK 35.94
- Support Level
- APVO $2.81
- GCTK $5.94
- Resistance Level
- APVO $13.11
- GCTK $15.90
- Average True Range (ATR)
- APVO 1.10
- GCTK 1.57
- MACD
- APVO 0.30
- GCTK -0.01
- Stochastic Oscillator
- APVO 4.08
- GCTK 0.56
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.